The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer

10.1038/s42003-023-05045-0

Saved in:

Bibliographic Details
Main Authors:	Yeo, Xun Hui, Sundararajan, Vignesh, Wu, Zhengwei, Phua, Zi Jin Cheryl, Ho, Yin Ying, Peh, Kai Lay Esther, Chiu, Yi-Chia, Tan, Tuan Zea, Kappei, Dennis, Ho, Ying Swan, Tan, David Shao Peng, Tam, Wai Leong, Huang, Ruby Yun-Ju
Other Authors:	BIOCHEMISTRY
Format:	Article
Published:	Springer Science and Business Media LLC 2023
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/242599
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
by: Yeo, Xun Hui, et al.
Published: (2023)

UNCOVERING THE NOVEL ROLES OF AXL AND THE ASSOCIATED THERAPEUTIC VULNERABILITIES
by: YEO XUN HUI
Published: (2021)

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
by: Xu, M.Z., et al.
Published: (2014)

Potential of tyrosine kinase receptor TIE-1 as novel therapeutic target in high-PI3K-expressing ovarian cancer
by: Zhang, X., et al.
Published: (2021)

SPESIFIKASI TYROSIN KINASE SPERMATOZOA SAPI
by: NURYO.SEKARNOTO, 060112855
Published: (2005)

Inhibitors of the tyrosine kinase signaling cascade for asthma
by: Wong, W.S.F.
Published: (2012)

Structure and physiology of the RET receptor tyrosine kinase
by: Ibáñez, C.F.
Published: (2016)

THE CPSBCD TYROSINE KINASE SYSTEM IN S.PNEUMONIAE
by: REI NAKAMOTO
Published: (2024)

An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease
by: Lee, Chingli, et al.
Published: (2021)

Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis
by: Teo, Y.L., et al.
Published: (2014)

Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
by: Bhave, Sayali, et al.
Published: (2022)

Will the requirement by the US FDA to simultaneously co-develop companion diagnostics (CDx) delay the approval of receptor tyrosine kinase inhibitors for RTK-rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) non-small cell lung cancer globally?
by: Ou, S.-H.I, et al.
Published: (2020)

Tyrosine kinase inhibitors: A new approach for asthma
by: Wong, W.S.F., et al.
Published: (2012)

Butein, a specific protein tyrosine kinase inhibitor
by: Yang, E.-B., et al.
Published: (2013)

Estimation of axle loads of heavy vehicles for pavement studies
by: Fwa, T.F., et al.
Published: (2014)

Role of Bruton's tyrosine kinase (Btk) in BCR and TLR signalling
by: LEE KOON GUAN
Published: (2011)

Novel inhibitor for fibroblast growth factor receptor tyrosine kinase
by: Naparat Kammasud, et al.
Published: (2018)

Design and synthesis of receptor tyrosine kinase inhibitors for anticancer treatment
by: Chawannuch Mudjupa
Published: (2023)

Tyrosine kinase c-Abl regulates the survival of plasma cells
by: Li, Y.-F, et al.
Published: (2020)

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition
by: Kran Suknuntha, et al.
Published: (2021)

Multimodal approaches to study the isoform-specific role of FynT tyrosine kinase in association with tau pathology in alzheimer's disease and related tauopathies
by: Low, Clara Ying Bei
Published: (2021)

Dynamic behavior of a vehicle with rear axle compliance steering
by: Xu, X.M, et al.
Published: (2020)

Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: Current understanding, challenges and recommendations
by: Teo Y.L, et al.
Published: (2016)

AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer
by: Engelsen, A.S.T., et al.
Published: (2021)

THE ROLE OF BRUTON'S TYROSINE KINASE IN REGULATING GUT IMMUNE HOMEOSTASIS AND INFLAMMATION
by: GUAN DI
Published: (2020)

A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis
by: Jennifer Smith, et al.
Published: (2018)

Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives
by: Yang, E.B., et al.
Published: (2014)

Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry
by: Kalesh, K.A., et al.
Published: (2014)

Differential expression of novel tyrosine kinase substrates during breast cancer development
by: Chen, Y., et al.
Published: (2012)

Non-destructive testing of train axle using ultrasonic phased arrays
by: Labayen, Rosario Rafael Joel
Published: (2021)

Non-destructive testing of train axle using ultrasonic phased array
by: Goh, Macs Chia Choon
Published: (2019)

Non-destructive testing of train axle using ultrasonic phased arrays
by: Muhammad Khalis Muhammad Rizauddin
Published: (2020)

Non-destructive testing of train axle using ultrasonic phased arrays
by: Lee, Lawrence Boon How
Published: (2018)

ESTIMATION OF VEHICLE GEOMETRY AND AXLE CONFIGURATION FROM TRAFFIC SURVEILLANCE CAMERA
by: LI BEIJI
Published: (2023)

A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42
by: Manser, E., et al.
Published: (2014)

Internalization of Aeromonas hydrophila by fish epithelial cells can be inhibited with a tyrosine kinase inhibitor
by: Tan, E., et al.
Published: (2014)

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
by: Lee, S.-C., et al.
Published: (2012)

EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
by: TEO YI LING
Published: (2015)

EFEKTIVITAS TYROSIN KINASE INHIBITOR PADA PENGHAMBATAN TOLERANSI ANTI NYERI OPIOID
by: Junaidi Khotib, S.Si., M.Kes., Ph.D., Apt., et al.
Published: (2008)

SRSF1-MEDIATED TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKAEMIA
by: SINNAKANNU JOANNA RAJESWARY
Published: (2018)